Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production

Apr 06, 2021

Endpoints News names Sean McClain, CEO and founder of Absci, to its 20 Under Forty in Biopharma list. Read more.

Related Media Highlights

Receive news directly in your email